Price
No data yet.
Social Signal Score
Revenue
$67.12MCompany Profile
- CEO
- Ziad Ghanem
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 972
- Beta
- 2.00
- Country
- CA
- Piotroski score
- 6 / 9 (Middling)
- Altman Z-score
- -0.86
Financials
Revenue
$67.12M+740155.9%Net Income
$-8.05MEBITDA
$4.82MFree Cash Flow
$7.38MEPS (diluted)
$-0.03Shares Outstanding (diluted)
309.36M+1046.3%Operating Expenses
$22.85MCash & Debt
$42.03MReturn of Capital
$314.0KQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $260.56M | $-81.33M | $-0.29 |
| 2024 | $306.68M | $-80.23M | $-0.28 |
| 2023 | $317.33M | $-91.10M | $-0.33 |
| 2022 | $247.83M | $-329.91M | $-1.24 |
| 2021 | $194.21M | $3.11M | $0.07 |
| 2020 | $198.32M | $-139.20M | $-0.83 |
| 2019 | $84.87M | $-215.79M | $-2.17 |
| 2018 | $6.83M | $-22.03M | $-0.17 |
| 2017 | $0.00 | $-6.81M | $-0.18 |
| 2016 | $0.00 | $-867.2K | $-0.03 |
| 2015 | $0.00 | $-760.5K | $-0.13 |
| 2014 | $0.00 | $-386.7K | $-0.13 |
Valuation
TRSSFhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
100+0.00%Social Signal Score
Mentions (2)
- Newsglobenewswire.com·6h ago·Neutral
TerrAscend Announces Results of Special Meeting of Shareholders TORONTO, Aug. 24, 2026 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis operator, today announced the results of its special meeting of shareholders held on August 24, 2026 (the “Special Meeting”). Common shareholders at the Special Meeting affirmatively approved the following resolutions:
View source ↗ - Newsglobenewswire.com·4d ago·Neutral
TerrAscend Announces Renewal and Replenishment of $10 Million Share Repurchase Program TORONTO, Aug. 20, 2026 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis company, today announced that its Board of Directors has authorized the Company to renew and replenish its normal course issuer bid (“NCIB”) to repurchase up to USD $10 million of the Company's common shares (“Shares”), from time to time over a 12-month perio
View source ↗
Earnings
Typical surprise -91.8% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Aug 10$-0.06 vs $-0.03miss
Estimates and results for TRSSF via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by TRSSF officers and directors.
No open-market trades in the recent filings. All 2 recent Form 4 entries were share awards, option exercises or tax withholding — pay, not decisions to buy or sell.
2 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.